-
Reserpine (N1867): Technical Guidance for Laboratory Use
2026-04-30
Reserpine (SKU N1867) provides a high-purity, workflow-stable standard for neurotransmitter depletion and antihypertensive mechanism research. It is not suitable for diagnostic or therapeutic applications. This article details practical handling and protocol parameters based on product dossier specifications.
-
LNP Delivery of Modified NGFR100W mRNA Alleviates Neuropathy
2026-04-30
This study demonstrates that lipid nanoparticle (LNP) delivery of chemically modified NGFR100W mRNA enables effective, sustained expression of a 'painless' nerve growth factor, accelerating nerve fiber recovery and attenuating neuropathic pain in a mouse model. The work highlights the therapeutic potential of 5-moUTP and similar nucleoside modifications for mRNA-based protein supplementation in neuroregenerative medicine.
-
Neuroligin 1 Deletion in Striatal D2-MSNs Drives Repetitive
2026-04-29
This study uncovers that loss of Neuroligin 1 in striatal D2 receptor-expressing medium spiny neurons leads to hyperactivation of these cells and excessive repetitive behaviors in mice. Through integrated behavioral, molecular, and single-nucleus RNA sequencing approaches, the authors implicate PKC overactivation and highlight circuit-level targets for intervention in autism spectrum disorder.
-
Cy3-dCTP: Precision Fluorescent Labeling in DNA Workflows
2026-04-29
Cyanine 3-dCTP (Cy3-dCTP) enables robust, high-sensitivity fluorescent labeling of DNA and cDNA with exceptional protocol flexibility. Leveraging APExBIO’s high-purity formulation, researchers can streamline direct enzymatic labeling, troubleshoot bottlenecks, and adapt protocols for advanced applications from PCR to in situ hybridization.
-
(+)-Bicuculline: Technical Use and Protocol Parameters Guide
2026-04-28
(+)-Bicuculline is a classical GABAA receptor antagonist for controlled in vitro and in vivo neuroscience workflows focused on dissecting inhibitory neurotransmission and synaptic NMDA receptor signaling. It is not intended for diagnostic, therapeutic, or clinical use; experimental reliability depends on precise solubility and storage practices.
-
HLTP1 Peptide Inhibits JNK-Driven Apoptosis in Hepatic IRI
2026-04-28
Xie et al. identify human liver transplantation peptide 1 (HLTP1) as a novel endogenous hepatoprotective peptide that attenuates hepatic ischemia-reperfusion injury (HIRI) by inhibiting Jun N-terminal kinase (JNK) phosphorylation and subsequent apoptosis. This work elucidates a promising translational strategy for mitigating graft injury in liver transplantation and establishes a mechanistic foundation for peptide-based therapies.
-
Auranofin as a Precision Tool for Cytoskeleton-Redox Crossta
2026-04-27
Explore how Auranofin, a leading thioredoxin reductase inhibitor, enables advanced research into cytoskeleton-dependent redox signaling and autophagy. This article uniquely connects redox disruption with mechanotransduction, offering novel insights for cancer and stress biology.
-
Perospirone Inhibits Kv1.5 Channels in Coronary Arterial Cel
2026-04-27
This study provides the first direct evidence that Perospirone, a second-generation antipsychotic, inhibits vascular Kv1.5 potassium channels in coronary arterial smooth muscle cells. These findings reveal an off-target cardiovascular action, underscoring the need for careful consideration of vascular effects in neuropsychiatric research using Perospirone.
-
Niclosamide: Precision STAT3 Inhibition for Advanced Cancer
2026-04-26
Niclosamide (5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) from APExBIO empowers researchers to achieve robust STAT3 pathway inhibition, enabling reproducible cell cycle arrest and apoptosis studies. This guide translates cutting-edge findings and hands-on protocols into actionable workflows, troubleshooting tips, and comparative insights for cancer biology applications.
-
Angiotensin Peptides Boost SARS-CoV-2 Spike–Receptor Binding
2026-04-25
Oliveira et al. (2025) reveal that endogenous angiotensin peptides, including truncated fragments, significantly amplify the binding between the SARS-CoV-2 spike protein and host cell receptors, particularly AXL. These findings highlight a novel molecular interaction at the intersection of cardiovascular signaling and viral pathogenesis, with direct implications for blood pressure regulation research and COVID-19 studies.
-
Tubastatin A: HDAC6 Inhibitor Workflows for Cardiac & Cancer
2026-04-24
Tubastatin A stands apart as a potent, highly selective HDAC6 inhibitor, unlocking advanced control of cell death and inflammation pathways in both cancer and cardiac models. This article distills the latest translational findings into practical protocols and troubleshooting insights, empowering researchers to harness Tubastatin A’s advantages for reproducible, high-sensitivity results.
-
Cholesterol Impairs Intracellular Trafficking of Lipid Nanop
2026-04-24
This study systematically dissects how cholesterol content in lipid nanoparticle (LNP) formulations hinders the endosomal escape and intracellular trafficking of nucleic acid cargo. The findings refine our understanding of LNP-mediated delivery, revealing cholesterol-driven retention in peripheral endosomes as a key barrier to efficient nucleic acid delivery.
-
Cy3-UTP: Illuminating RNA Structure–Function for Translation
2026-04-23
This thought-leadership article explores how Cy3-UTP, a Cy3-modified uridine triphosphate, is transforming RNA research by enabling precise, photostable fluorescent labeling. We connect advances in polyanion-engineered RNA nanoparticles with Cy3-UTP’s utility in in vitro transcription, RNA-protein interaction studies, and high-throughput structural assays. Drawing on recent innovations in polymeric RNA delivery and referencing leading work on ternary nanoparticles, we provide strategic guidance for translational researchers seeking to bridge mechanistic insight and clinical application.
-
Paclitaxel (Taxol) A4393: Reliable Cell Cycle Arrest in Canc
2026-04-23
This article delivers scenario-driven guidance for optimizing cell viability and cytotoxicity assays with Paclitaxel (Taxol) (SKU A4393). By addressing real laboratory challenges—ranging from protocol reproducibility to nuanced vendor selection—the discussion equips cancer researchers with evidence-based strategies and data-backed best practices, ensuring robust and reliable results in both standard and advanced oncology workflows.
-
Polyanion-Engineered Ternary RNA Nanoparticles: Structure–Fu
2026-04-22
This study systematically dissects how PEGylated polyanions modulate the structure and function of ternary RNA nanoparticles (TNPs) for nucleic acid delivery. By linking polyanion chemistry to extracellular stability, protein binding, and transfection efficacy, the work establishes a framework for high-throughput screening and rational design of polymeric RNA carriers, challenging the dominance of lipid-based systems.